Dr. Racke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2050 Kenny Rd
Columbus, OH 43221Phone+1 614-293-6526Fax+1 614-293-4724
Education & Training
National Institutes of Health Clinical CenterFellowship, Neuroimmunology & Multiple Sclerosis, 1989 - 1991
Emory University School of MedicineResidency, Neurology, 1986 - 1989- Emory University School of MedicineInternship, Internal Medicine, 1985 - 1986
Rutgers New Jersey Medical SchoolClass of 1985
Certifications & Licensure
OH State Medical License 2006 - 2026
TX State Medical License 1999 - 2025
MD State Medical License 1990 - 1995- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Harry Weaver Neuroscience Scholar National Multiple Sclerosis Society
Clinical Trials
- High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study Start of enrollment: 2006 Jul 01
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Start of enrollment: 2007 Mar 01
Publications & Presentations
PubMed
- Self-reported longitudinal COVID-19 vaccination reactogenicity profiles in persons with multiple sclerosis.Farren B S Briggs, Hollie Schmidt, Farrah J Mateen, Stephanie Buxhoeveden, Bruce F Bebo
Multiple Sclerosis and Related Disorders. 2024-12-29 - 1 citationsMachine Learning Analysis Using RNA Sequencing to Distinguish Neuromyelitis Optica from Multiple Sclerosis and Identify Therapeutic Candidates.Lukasz S Wylezinski, Cheryl L Sesler, Guzel I Shaginurova, Elena V Grigorenko, Jay G Wohlgemuth
The Journal of Molecular Diagnostics. 2024-06-01 - IL-1 receptor 1 signaling shapes the development of viral antigen-specific CD4T cell responses following COVID-19 mRNA vaccination.Hong-Jai Park, Min Sun Shin, Junghee J Shin, Hyoungsu Kim, Byunghyun Kang
Ebiomedicine. 2024-05-01
Press Mentions
Royal Philips, Medtronic Neurovascular Join WSO Advocacy CoalitionOctober 24th, 2024- PET/MRI Shows Promise in Patients with Large Vessel VasculitisAugust 27th, 2024
- Micro-SPECT Shows Microplastics Cause Renal Failure in MiceAugust 23rd, 2024
- Join now to see all
Grant Support
- T Cell Activation Requirement In Autoimmune DemyelinationNational Institute Of Neurological Disorders And Stroke2009–2010
- Ninth International Congress Of NeuroimmunologyNational Institute Of Neurological Disorders And Stroke2008
- Clinical Trial: Betaseron/Betaferon In MSNational Center For Research Resources2008
- Immunopathogenesis Of Multiple SclerosisNational Institute Of Neurological Disorders And Stroke2006–2008
- T Cell Activation Requirement In Autoimmune DemyelinatioNational Institute Of Neurological Disorders And Stroke2004–2006
- Immunopathogenesis Of Multiple SclerosisNational Institute Of Neurological Disorders And Stroke2003–2006
- Tcell Activation Requirement In Autoimmune DemyelinationNational Institute Of Neurological Disorders And Stroke2003
- T Cell Activation In Autoimmune DemyelinationNational Institute Of Neurological Disorders And Stroke1999–2002
- Mechanism Of Copaxone Therapy In MSNational Institute Of Allergy And Infectious Diseases1999–2002
- T Cell Activation In Autoimmune DemyelinationNational Institute Of Neurological Disorders And Stroke1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
